Clinical trial

Study Evaluating Etanercept in Moderate to Severe Asthma

NCT00141791

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-05-01

PhasePHASE2

Study timeline

Study start (unknown)2005-05-01Date precision: month

Registry last updated2009-08-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Asthmaunresolved

Interventions

EtanerceptDRUG

Sponsors & collaborators

Wyeth is now a wholly owned subsidiary of Pfizerlead sponsor

Mapped research locations

BostonMassachusetts, United States1 BirminghamAlabama, United States1 PortlandOregon, United States1 DenverColorado, United States1 RichmondVirginia, United States1 Winston-SalemNorth Carolina, United States1 MadisonWisconsin, United States1 SarasotaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00141791 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.